Cue Biopharma shareholders approved reverse stock split proposal at annual meeting
Share
Listen to the news
Cue Biopharma shareholders approved reverse stock split proposal at annual meeting
  • Cue Biopharma shareholders met April 13, 2026.
  • Investors ratified RSM US LLP as independent registered public accounting firm for fiscal 2026.
  • Shareholders authorized amendment to charter to allow a reverse stock split within a 1-for-30 to 1-for-50 range, with ratio and timing set by board.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cue Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-152826), on April 13, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending